Showing results (471-480 of 618) with videos related to
Sort By:
Pageof 62
Bone Marrow Transplantation|July 5, 2005
Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemiaM Sauer, C Bettoni, M Lauten, et al.Diabetes & Metabolic Syndrome|July 22, 2017
Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional studyS Ray, A M Beatrice, A Ghosh, et al.British Journal of Cancer|April 1, 1990
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II studyN Thatcher, H Dazzi, M Mellor, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|January 31, 2002
A randomized controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh--narrowing the options for the National Malaria Control Programme?M R Rahman, D C Paul, M Rashid, et al.Diabetes, Obesity & Metabolism|November 26, 2014
Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double-blind, crossover studyS Sha, D Polidori, K Farrell, et al.Journal of Clinical Microbiology|July 3, 1998
Molecular epidemiology of reemergent Vibrio cholerae O139 Bengal in IndiaA K Mukhopadhyay, A Basu, P Garg, et al.Biochemistry|August 22, 2001
Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor designR T Turner, G Koelsch, L Hong, et al.Molecular Biology Reports|September 15, 2011
Molecular characterization of intra-population variability of Jatropha curcas L. using DNA based molecular markersShaik G Mastan, Pamidimarri D V N Sudheer, H Rahman, et al.Prenatal Diagnosis|January 1, 1985
Evaluation of a prenatal screening procedure for beta-thalassaemia carriers in a Chinese population based on the mean corpuscular volume (MCV)A Ghosh, J S Woo, C W Wan, et al.British Journal of Cancer|July 1, 1992
Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trialM H Gilleece, J H Scarffe, A Ghosh, et al.Pageof 62